 CAMBRIDGE, Mass., July 07, 2021 GLOBE NEWSWIRE -- Codiak BioSciences, Inc. Nasdaq: CDAK, a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics as a new class of medicines, today announced that its President and Chief Executive Officer, Douglas E. Williams, Ph.D., will participate in two virtual panel discussions and virtual 1x1 meetings at the William Blair Biotech Focus Conference 2021. Details are as follows: 